|
|
|
|
|
|
|
|
|
|
|
|
|
19.02.26 - 07:03
|
Materialise Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
|
|
|
Regulated information1LEUVEN, Belgium--(BUSINESS WIRE)--$MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Highlights – Fourth Quarter 2025
Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025 from 65,680 kEUR for the corresponding 2024 period, boosted by 16.3% growth in our Materialise Medical segment.
Gross profit as a percentage of revenue for the fourth quarter of 2025 increased to 58.1%, compared to 55.4% for the corresponding 2024 period.
Adjusted EBIT amounted to 3,980 kEUR for the fourth quarter of 2025, representing 5.7% of consolidated revenue, compared to (1,195) kEUR for the corresponding period.
Net result for the fourth quarter of 2025 was 6,206 kEUR, or 0.11 EUR per diluted share, compared to a net result of 2,907 kEUR, or 0.05 EUR per diluted shar...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05.02.26 - 17:42
|
X-FAB Fourth Quarter and Full Year 2025 Results (Business Wire)
|
|
|
Intermediate declaration by the Board of DirectorsTESSENDERLO-HAM, Belgium--(BUSINESS WIRE)--Regulatory News:
X-FAB (BOURSE:XFAB):
Highlights Q4 2025:
Revenue was USD 222.3 million, up 18% year-on-year (YoY) and down 3% quarter-on-quarter (QoQ)
Excluding the impact from revenue recognized over time (IFRS 15), revenue was USD 218.1 million, within the guided range of USD 215-225 million.
EBITDA at USD 42.3 million, up 6% YoY and down 21% QoQ, impacted by a USD 9.3 million one-off item related to the SiC business in Q4 2025
EBITDA margin of 19.0%; excluding IFRS 15 impact, EBITDA margin was 19.2%, compared to the guidance of 22.5-25.5%
EBIT was USD 9.8 million, down 7% YoY and down 59% QoQ
Highlights 2025
Revenue was USD 870.3 million, up 7% YoY; excluding IFRS 15 impact, revenue was USD 867.6 million within the guidance range of USD 863-873 million.
Core business – automotive, industrial, and medical – was USD 814.2 million*, up 7% YoY and representing a share of 94%* of total revenues
EBITDA at USD 19...
|
|
|
|
|
04.02.26 - 22:09
|
Materialise NV to Report Fourth Quarter 2025 Earnings on Thursday, February 19, 2026 (Business Wire)
|
|
|
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the fourth quarter ended December 31, 2025 on Thursday, February 19, 2026 at 2:30 a.m. ET/8:30 a.m. CET.
Senior management will hold a conference call to discuss the fourth quarter 2025 financial results on Thursday, February 19, 2026 at 8:30 a.m. ET/1:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's conference call: Fourth Quarter 2025 Conference Call.
A live audio webcast will be accessible through http://investors.materialise.com. The webcast of the conference call will be archived on the company's website.
About Materialise
Materialise incorporate...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
